CLINICAL_TRIALS
trial_result
· 2017-06-14
Clinical Trial Update: Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist [Phase 4]
Summary
Phase 4 trial examining changes in bone turnover with exposure to a GLP-1 receptor agonist in Type 2 Diabetes Mellitus; the study was terminated and results wer…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Type 2 Diabetes Mellitus, Bone Remodeling | Phase 4 | Status: TERMINATED | Results posted: 2017-06-14